×

Shareholder Information

Company information

Registered name: e-therapeutics plc
Country of incorporation: England and Wales
Main country of operation: UK
Company number: 04304473
Registered office: 17 Blenheim Office Park, Long Hanborough Oxfordshire, OX29 8LN

Listing

e-Therapeutics is listed on the Alternative Investment Market of the London Stock Exchange (AIM), with ticker symbol ETX.

The Company has not applied or agreed to have any of its securities (including its AIM securities) admitted to or traded on any other exchanges or trading platforms.

Securities in issue

Number of AIM securities in issue: 322,427,853 ordinary shares of 0.1p
Percentage of AIM securities not in public hands: 44.88%
Listing: AIM
Index: FTSE AIM All Share
Sector: Pharmaceutical & Biotechnology
Symbol: ETX

There are no restrictions on the transfer of the Company’s shares.

Last updated: 15 April 2020

Significant Shareholdings

  • Richard Griffiths and controlled undertakings – 94,800,167 (29.40%)
  • Ali Mortazavi - 49,000,000 (15.20%)
  • Trillian Ltd - 28,333,333 (8.79%)
  • Robert Quested - 26,240,834 (8.14%)
  • Lombard Odier Asset Management – 21,394,589 (6.64%)
  • David Norwood - 17,000,000 (5.27%)

Last updated: 23 June 2020

Advisors

Nominated advisor and broker
Numis Securities Limited
10 Paternoster Row
London
EC4M 7LT
020 7260 1000
www.numis.com

Auditors
Grant Thornton UK LLP
30 Finsbury Square
London
EC2A 1AG
www.grantthornton.co.uk

Solicitors
Womble Bond Dickinson (UK) LLP
St. Ann’s Wharf
112 Quayside
Newcastle upon Tyne
NE1 3DX
Tel: +44 (0) 844 984 1500
Fax: +44 (0) 844 984 1501
www.bonddickinson.com

Registrars
Neville Registrars Limited
Neville House
18 Laurel Lane
Halesowen
West Midlands
B63 3DA
Tel: +44 (0) 121 585 1131
Fax: +44 (0) 121 585 1132
www.nevilleregistrars.co.uk

Bankers
Bank of Scotland
PO Box No 10
38 St. Andrews Square
Edinburgh
EH2 2AD
Tel: +44 (0) 131 465 3900
www.bankofscotland.co.uk

Scroll to Top